Neurodegeneration causes inexorable loss of neurons and function in both diseases and aging. Neurodegeneration damage produces a range of progressive disabilities from cognitive decline, behavioral and mood disorders to problems with movement, co-ordination, and sensory dysfunction. Neurodegeneration is a major and growing public health issue which in its broadest sense embraces classical neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, as well as multiple sclerosis (MS), diabetes, and acute brain injury among many other conditions. This chapter discusses the clinical and pathophysiological features of neurodegeneration in MS.
|Title of host publication||NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers|
|Publisher||Springer International Publishing|
|Publication status||Published - 2018|
|Name||NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers|
Petzold, A. (2018). Neurodegeneration and multiple sclerosis. In NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers (pp. 379-400). (NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers). Springer International Publishing. https://doi.org/10.1007/978-3-319-72938-1_18